Milestone Pharmaceuticals
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell MIST and other ETFs, options, and stocks.About MIST
Milestone Pharmaceuticals, Inc. engages in the development and commercialization of cardiovascular medicines. Its lead product candidate etripamil, is a novel, potent and short-acting calcium channel blocker that is designed as a rapid-onset nasal spray to be self-administered by patients.
MIST Key Statistics
Stock Snapshot
The current Milestone Pharmaceuticals(MIST) stock price is $1.56, with a market capitalization of 182.97M. The stock trades at a price-to-earnings (P/E) ratio of -2.39.
As of 2026-05-15, Milestone Pharmaceuticals(MIST) stock has fluctuated between $1.53 and $1.61. The current price stands at $1.56, placing the stock +1.6% above today's low and -3.4% off the high.
Milestone Pharmaceuticals(MIST) shares are trading with a volume of 487.8K, against a daily average of 1.75M.
During the past year, Milestone Pharmaceuticals(MIST) stock moved between $1.00 at its lowest and $3.06 at its peak.
During the past year, Milestone Pharmaceuticals(MIST) stock moved between $1.00 at its lowest and $3.06 at its peak.
MIST News
Reports Q1 revenue $238,000, consensus $37.64M. “We’re excited to report on our first quarter of sales for CARDAMYST for paroxysmal supraventricular tachycardia...
Milestone Pharmaceuticals (MIST) came out with a quarterly loss of $0.2 per share versus the Zacks Consensus Estimate of $0.06. This compares to a loss of $0.31...
Analyst ratings
83%
of 6 ratingsPeople also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.